Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Use of Cannabinoids for Spasticity and Pain Management in MS.
Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like disease.
Sunlight exposure and multiple sclerosis in a tropical country.
The Relationship Between Familial Mediterranean Fever Gene (MEFV) Mutations and Clinical and Radiological Parameters in Multiple Sclerosis Patients.
MS patients must have access to the best treatment options.
Axonal transport rate decreased at the onset of optic neuritis in EAE mice.
Sodium ((23)Na) ultra-short echo time imaging in the human brain using a 3D-Cones trajectory.
Fabry disease - underestimated in the differential diagnosis of multiple sclerosis?
The changing landscape of voltage-gated calcium channels in neurovascular disorders and in neurodegenerative diseases.
Interferon alpha association with neuromyelitis optica.
Cost-utility analysis of disease-modifying drugs in relapsing-remitting multiple sclerosis in Iran.
Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System?
What Do Effective Treatments for Multiple Sclerosis Tell Us about the Molecular Mechanisms Involved in Pathogenesis?
Prevalence and incidence of Multiple Sclerosis in Campobasso (Molise region chieftown, southern Italy).
Bioconcentration, metabolism and neurotoxicity of the organophorous flame retardant 1,3-dichloro 2-propyl phosphate (TDCPP) to zebrafish.
Multifocal VEP assessment of optic neuritis evolution.
CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis.
Sex-Based Differences in Multiple Sclerosis (MS): Part II: Rising Incidence of Multiple Sclerosis in Women and the Vulnerability of Men to Progression of this Disease.
Psychometric properties of quality of life and health-related quality of life assessments in people with multiple sclerosis.
Recovery of peripheral muscle function from fatiguing exercise and daily physical activity level in patients with multiple sclerosis: A case-control study.
[Release-active antibodies to S100 protein are able to improve the experimental allergic encephalomyelitis].
Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination.
Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
Aging of the cingulum in the human brain: Preliminary study of a diffusion tensor imaging study.
Purinergic Signaling and the Functioning of the Nervous System Cells.
Pages
« first
‹ previous
…
527
528
529
530
531
532
533
534
535
…
next ›
last »